» Articles » PMID: 32820257

The COVID-19 XPRIZE and the Need for Scalable, Fast, and Widespread Testing

Citing Articles

Scalable solutions for global health: the SalivaDirect model.

Wyllie A, Choate B, Burke L, Ali Y Front Cell Infect Microbiol. 2024; 14:1446514.

PMID: 39534700 PMC: 11554656. DOI: 10.3389/fcimb.2024.1446514.


Comparison of Electronegative Filtration to Magnetic Bead-Based Concentration and V2G-qPCR to RT-qPCR for Quantifying Viral SARS-CoV-2 RNA from Wastewater.

Babler K, Amirali A, Sharkey M, Williams S, Boone M, Cosculluela G ACS ES T Water. 2023; 2(11):2004-2013.

PMID: 37601294 PMC: 10438908. DOI: 10.1021/acsestwater.2c00047.


Variations in national surveillance reporting for Mpox virus: A comparative analysis in 32 countries.

Panag D, Jain N, Katagi D, De Jesus Cipriano Flores G, Silva Dutra Macedo G, Rodrigo Diaz Villa G Front Public Health. 2023; 11:1178654.

PMID: 37143972 PMC: 10151817. DOI: 10.3389/fpubh.2023.1178654.


Vivid COVID-19 LAMP is an ultrasensitive, quadruplexed test using LNA-modified primers and a zinc ion and 5-Br-PAPS colorimetric detection system.

Szobi A, Buranovska K, Vojtassakova N, Lovisek D, Ozbasak H, Szeibeczederova S Commun Biol. 2023; 6(1):233.

PMID: 36864129 PMC: 9979146. DOI: 10.1038/s42003-023-04612-9.


Clinical Performance and Trends during the First Two Months of Monkeypox Virus PCR Testing at Two United States Reference Labs.

Lieberman N, Mathias P, Bradley B, Greninger A J Clin Microbiol. 2022; 60(12):e0137122.

PMID: 36409134 PMC: 9769734. DOI: 10.1128/jcm.01371-22.